Rodríguez-Agudo, R, González-Recio, I, Serrano-Maciá, M, Bravo, M, Petrov, P, Blaya, D, Herranz, JM, Mercado-Gómez, M, Rejano-Gordillo, CM, Lachiondo-Ortega, S, Gil-Pitarch, C, Azkargorta, M, Van Liempd, SM, Martinez-Cruz, LA, Simao, AL, Elortza, F, Martín, C, Nevzorova, YA, Cubero, FJ, Delgado, TC, Argemi, J, Bataller, R, Schoonjans, K, Banales, JM, Castro, RE, Sancho-Bru, P, Avila, MA, Julve, J, Jover, R, Mabe, J, Simon, J, Goikoetxea-Usandizaga, N, Martínez-Chantar, ML. Anti-miR-873-5p improves alcohol-related liver disease by enhancing hepatic deacetylation via SIRT1. Jhep Reports. 2024; 6(1)DOI:10.1016/j.jhepr.2023.100918. PMID:38192540. IF:7.500(Q1/2D).

Soldevila B., Alarcón L., Vlacho B., Real J., Hernández M., Cos X., Franch-Nadal J., Mauricio D.. Trends in the prevalence of gestational diabetes in Catalonia from 2010 to 2019. Primary Care Diabetes. 2024; 18(2)DOI:10.1016/j.pcd.2023.12.007. PMID:38228411. IF:2.300(Q2/5D).

Gómez-Peralta, F, Valledor, X, López-Picado, A, Abreu, C, Fernández-Rubio, E, Cotovad, L, Pujante, P, García-Fernández, E, Azriel, S, Corcoy, R, Pérez-González, J, Ruiz-Valdepeñas, L. Ultrarapid Insulin Use Can Reduce Postprandial Hyperglycemia and Late Hypoglycemia, Even in Delayed Insulin Injections: A Connected Insulin Cap-Based Real-World Study. Diabetes Technology & Therapeutics. 2024; 26(1)DOI:10.1089/dia.2023.0321. PMID:37902762. IF:6.300(Q1/2D).

Ramírez-Morros, A, Berenguera, A, Millaruelo, L, Buil-Cosiales, P, Garcia, CG, Cos, X, Lachica, LA, Artola, S, Millaruelo, JM, Mauricio, D, Franch-Nadal, J. Impact of Gender on Patient Experiences of Self-Management in Type 2 Diabetes: A Qualitative Study. Patient Preference and Adherence. 2024; 18DOI:10.2147/PPA.S466931. PMID:39290823. IF:2.000(Q2/4D).